Crossmark

Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer

Crossref DOI link: https://doi.org/10.1186/s12885-018-4816-5

Published Online: 2018-10-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McGrath, Sophie Elena

Annels, Nicola

Madhuri, Thumuluru K.

Tailor, Anil

Butler-Manuel, Simon A.

Morgan, Richard

Pandha, Hardev

Michael, Agnieszka https://orcid.org/0000-0002-7262-6227
License Information

Text and Data Mining valid from 2018-10-03
More Information

Article History

Received: 18 May 2018

Accepted: 13 September 2018

First Online: 3 October 2018

Ethics approval and consent to participate

: This study was approved by the London - Brighton & Sussex Research Ethics Committee (REC no: 09/H1103/50) and conducted between 2009 and 2014.Informed consent was taken from each patient prior to their planned surgery, with consent forms filed within their hospital patient record.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.